5% STAKE4598.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Delta-Fly Pharma to 21.47%

Stake history

15%20%25%30%35%40%45%43.20%Aug 17Aug 17: 43.20% · S100YX1041.97%Aug 28Aug 28: 41.97% · S100YZ7033.39%Sep 8Sep 8: 33.39% · S100Z0SR32.11%Sep 9Sep 9: 32.11% · S100Z11422.71%Sep 16Sep 16: 22.71% · S100Z2FG20.65%Oct 7Oct 7: 20.65% · S100Z6NB22.55%Oct 8Oct 8: 22.55% · S100Z6RS21.47%Oct 21Oct 21: 21.47% · S100Z95T
15%20%25%30%35%40%45%43.20%Aug 17Aug 17: 43.20% · S100YX1041.97%Aug 28Aug 28: 41.97% · S100YZ7033.39%Sep 8Sep 8: 33.39% · S100Z0SR32.11%Sep 9Sep 9: 32.11% · S100Z11422.71%Sep 16Sep 16: 22.71% · S100Z2FG20.65%Oct 7Oct 7: 20.65% · S100Z6NB22.55%Oct 8Oct 8: 22.55% · S100Z6RS21.47%Oct 21Oct 21: 21.47% · S100Z95T

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-10-21 10:33 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 21.47%, previous report: 22.55%.

Open the price chart on TradingView.

Source: EDINET S100Z95T ↗ · PDL1.0 · Not investment advice